Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that Dr. Steve Cutler has been appointed to the newly created position of chief operating officer, Icon.

Cutler joined Icon in November 2011 as group president, clinical research services. In his new role as chief operating officer, Cutler has responsibility for all of Icon operational units, covering early phase, clinical, laboratories, commercialization and outcomes and DOCS FSP & resourcing. Cutler also will take responsibility for Icon’s sales and marketing and strategic alliance teams.

Within Cutler's team, Dr. Nuala Murphy has been appointed president, Icon Clinical Services and Jim Miskel has been appointed executive vice president and general manager, Icon Laboratory Services.

Murphy joined Icon in 2012 as executive vice president, global clinical operations and data management, bringing to Icon over 22 years' experience within the pharmaceutical and CRO industries. Murphy will oversee Icon’s global clinical services, comprising clinical and data operations, study startup, project management, clinical risk management, technology services and clinical scientific operations.

Miskel joined Icon in November 2013 and will lead Icon's newly combined central and bioanalytical laboratories group. He brings laboratory and pharmaceutical industry experience to Icon, having previously held senior positions with Harlan Laboratories, MDS Pharma Services, Wyeth Pharmaceuticals and McKinsey & Company.

Ciaran Murray, CEO, Icon, said, "We continually review our structure to ensure that as the market evolves, our organization can continue to provide customers with innovative and integrated solutions across our various service lines and business units. Bringing all operational units under Cutler's leadership will allow us to further enhance the support we can offer to our customers' development programs.”